Dr. Taha supervised and Co-supervised the following M.Sc. and Ph.D. research projects:
1) The Utilization of Catalyst Software for the Discovery of New Potential Anticancer Agents. Ihab Mustafa Almasri (M.Sc. Thesis), May 2003.
2) Synthesis and Characterization of Novel Chiral Polymer- Aluminum Composite and Its Evaluation as a New Stationary Phase for the Chromatographic Separation of Optical Isomers. Muhammed Hashem Zweiri (M.Sc. Thesis), November 2002.
3) The Synthesis and Microbiological Evaluation of Some Novel Derivatives of Some Natural and Synthetic Polymers. Reema A. K. Abu Khalaf, July 2002.
4) Synthesis of Iron-Crosslinked Benzyl and Methyl Hydroxamated Natural Polymers and its In Vitro Evaluation as Potential Matrix Material for Oral Sustained-Release Beads. Reem H. AL-Qieshawi (M.Sc. Thesis), December 2001.
5) Predicting Tablet Properties by the Novel Use of Molecular Modeling and Quantitative Structure Property Relationship Analysis. Maha A. Habash (M.Sc. Thesis), August 2001.
6) Development of in-silico pharmacophoric models for inhibitors of important key receptors and enzymes involved in the pathogenesis of a group of interrelated circulatory and cardiovascular diseases. Dhia Zaki Dawoud. (M.Sc. Thesis) December 2003.
7) The utilization of Catalyst software for the discovery of potential anti-viral agents. Hamadeh Tarazi (M.Sc. Thesis). December 2003.
8) Development of valid analytical technique for the analysis of the experimental neuromuscular blocker EXP150 developed at the faculty of Pharmacy/University of
9) Preparation of taste-masking microspheres for the cephalosporin cefataxim axetil. Abdul Hamid Odeh (M.Sc. Thesis). 2005.
10) Generation Of An Optimal Pharmacophoric Model For Quorum Sensing Agonists And Antagonists in Pseudomonas aeruginosa Employing Ligand-Based Modeling Techniques And Subsequent Experimental Validation. Waleed Zalloum (M.Sc. Thesis). 2005
11) Modeling the Pharmacophoric Properties of the Skin Pigmentation Enzyme “Tyrosinase” followed by in-silico and in-vitro screening for new hits. Rushdi Abu Hamdah (M.Sc. Thesis). 2007
12) In silico modeling and search for new neurnamindase inhibitors as potential treatments for avian flu. Areej Abu Hammad (M.Sc. Thesis). 2006
13) Docking, CoMFA and Pharmacophor Modeling of the MurF enzyme inhibitors for the discovery of new selective anti-bacterial agents and subsequent experimental validation. Naji Atallah (M.Sc. Thesis). 2007
14) Discovery of new anti-diabetic GSK3-b inhibitors using ligand-based pharmacophore mopdelling and experimental validation. Mohammad Al-Ghussein (M.Sc. Thesis). 2007.
15) Preparation of novel matrices based on alginate-surfactant composites via ionotropic crosslinking with calcium and/or zinc and their evaluation as sustained release formulations using chlorpeniramine maleate as model drug. Wissam Nasser (M.Sc. Thesis). 2007
16) Discovery of dual protein tyrosine phosphatase 1B and dipeptidyl peptidase IV inhibitors via pharmacophore and QSAR analysis followed by in-silico screening and in-vitro and in-vivo experimental validation. Ihab Al-Masri (Ph.D. Thesis). September-2008.
17) Discovery of new cholesteryl ester transfer protein (CETP) inhibitorsvia ligand-based pharmacophore modelling and QSAR analysis and subsequent hit optimization. Reema Abu Khalaf (Ph.D. Thesis). Present.
18) Discovery and Optimization of new β-D-Glucosidase and β-D-Galactosidase inhibitors via Pharmacophore, QSAR analysis, in-silico Screening and in-vitro Validation. Ahmad Al-Mutanabi (Ph.D. Thesis). Present.
19) Discovery of new Hormone Sensitive Lipase inhibitors via Ligand-based Pharmacophore modeling and QSAR analysis followed by experimental validation. Lina Dahabeyah (M.Sc. Thesis). August-2008.
20) Preparation of novel matrices based on alginate-chitosan phthalate composites via ionotropic crosslinking with calcium(II) and/or zinc(II) and their evaluation as sustained release formulations using chlorpheniramine maleate as model drug. Arwa Matter (M.Sc. Thesis). August -2008.
21) Preparation of novel controlled-release matrices based on alginate small carboxylic acid composites via ionotropic crosslinking with calcium(II) and/or zinc(II) and their evaluation as sustained release formulations using methylene blue as model drug. Reema Ottom (M.Sc. Thesis). August-2008.
22) Design and Synthesis of Azole Containing Abeitic Acid Derivatives and Their Biological Evaluation. Tareq Al-Hraznah (M.Sc. Thesis). November-2008.
23) Discovery of new estrogen-receptor b (ERB) selective antagonists as potential anti-inflammatory agents. Mai Taraira (M.Sc. Thesis). Present.
24) Discovery and Chemical Optimizatioon Of Novel Rho Kinase (Rock II) and/or ca2+/calmodulin-dependent protein kinase II (CAMKII) as potential New Anti-Hypertensive Agents. Rand Shahin (Ph.D. Thesis). Present
25) Discovery and optimization of new anticancer agents based on daul inhibition of heat shock protein 90 and cyclin dependent kinase-1 via ligand-based and structure-based modelling followed by in-silico screening, biological evaluation and chemical optimization. Mahmoud A.Al-Sha’er (Ph.D. Thesis). Present
26) Discovery and Optimization of New Glucokinase Enzyme Activators and/or Glycogen Phosphorylase Enzyme Inhibitors as Potential Anti-Diabetic Agents. Maha A. Habash (Ph.D. Thesis). Present.
27) Discovery and Optimization of new Fructose-1,6-Bisphosphatase (FBP) inhibitors as potential antidiabetic agents. Rabab F. Tayyem (Ph.D. Thesis). Present
